Treatment with mitiperstat, intended to target the neutrophil–MPO inflammatory pathway, did not improve symptoms or exercise function in individuals with heart failure with preserved or mildly reduced ejection fraction.
Lars H. Lund, Carolyn S. P. Lam, P. E. Pizzato et al.· Nature Medicine· 1 citation
Survivors of all 21 cancer subtypes had a higher associated rate of VTE compared with the background population, with the highest incidence rates found for multiple myeloma.
A. Yafasova, Guo-Li Sun, M. Hutchings et al.· European Journal of Preventi...· 0 citations
BACKGROUND
Left atrial (LA) enlargement has been proposed to increase stroke risk independent of atrial fibrillation (AF), but evidence accounting for AF over time is limited. We tested whether the association between LA enlargement and stroke persist independent of new-onset AF.
METHODS
In this observational study,...
J. J. Loft, J. Kühl, M. Pham et al.· Journal of the American Hear...· 0 citations
BACKGROUND
The ORBI Risk Score predicts in-hospital cardiogenic shock after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). Whether high-risk patients also have more systemic inflammation, larger infarcts and higher long-term mortality is not known.
METHODS
In a DANAMI...
J. Kunkel, J. Lønborg, M. Frydland et al.· European heart journal. Acut...· 0 citations
BACKGROUND
SGLT2 inhibitors (SGLT2i) reduce mortality in left heart failure. In pulmonary arterial hypertension (PAH), preclinical data suggest SGLT2i improve right ventricular function through metabolic modulation and inhibition of vascular remodeling via smooth muscle cell pathways. The DAPAH trial evaluated whether...
M. Ersbøll, J. Kjærgaard, K. Waidtløw et al.· The Journal of Heart and Lun...· 1 citation
Prognosis after transcatheter aortic valve implantation (TAVI) keeps improving, yet some high-risk groups persist with chronic kidney disease being one. Contemporary data on the prognostic importance of pre-TAVI kidney function are sparse, leaving uncertainty regarding which patients derive limited benefit from T...
Martha Meibom, J. Petersen, Victoria Mikkelsen et al.· European Heart Journal· 0 citations
In patients aged ≥75 years, clear evidence of a long-term (10 years) benefit of complete revascularization was not demonstrated, and the finding should be interpreted as inconclusive.
Yan Zhou, B. T. Özbek, J. Marquard et al.· European heart journal. Acut...· 0 citations
Artificial intelligence-based CCTA analysis identified a large low-risk subgroup and a smaller subgroup at increased HF risk, supporting further evaluation of opportunistic HF assessment from CCTA.
A. O. Olesen, K. Miger, S. Ørting et al.· European Heart Journal - Dig...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.